|
1
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ajani JA, Ota DM, Jessup JM, Ames FC,
McBride C, Boddie A, Levin B, Jackson DE, Roh M and Hohn D:
Resectable gastric carcinoma. An evaluation of preoperative and
postoperative chemotherapy. Cancer. 68:1501–1506. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang D and Fan D: Multidrug resistance in
gastric cancer: Recent research advances and ongoing therapeutic
challenges. Expert Rev Anticancer Ther. 7:1369–1378. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kartal-Yandim M, Adan-Gokbulut A and Baran
Y: Molecular mechanisms of drug resistance and its reversal in
cancer. Crit Rev Biotechnol. 36:716–726. 2016.
|
|
6
|
Borst P: Genetic mechanisms of drug
resistance. A review Acta Oncol. 30:87–105. 1991. View Article : Google Scholar
|
|
7
|
Cui J, Jiang W, Wang S, Wang L and Xie K:
Role of Wnt/β-catenin signaling in drug resistance of pancreatic
cancer. Curr Pharm Des :. 2464–2471. 2012. View Article : Google Scholar
|
|
8
|
Abdi J, Chen G and Chang H: Drug
resistance in multiple myeloma: Latest findings and new concepts on
molecular mechanisms. Oncotarget. 4:2186–2207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang Z, Guo L, Liu D, Sun L, Chen H, Deng
Q, Liu Y, Yu M, Ma Y, Guo N, et al: Acquisition of resistance to
trastuzumab in gastric cancer cells is associated with activation
of IL-6/STAT3/ Jagged-1/Notch positive feedback loop. Oncotarget.
6:5072–5087. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
McAuliffe SM, Morgan SL, Wyant GA, Tran
LT, Muto KW, Chen YS, Chin KT, Partridge JC, Poole BB, Cheng KH, et
al: Targeting Notch, a key pathway for ovarian cancer stem cells,
sensitizes tumors to platinum therapy. Proc Natl Acad Sci USA.
109:E2939–E2948. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ren T, Lin S, Wang Z and Shang A:
Differential proteomics analysis of low- and high-grade of
astrocytoma using iTRAQ quantification. Onco Targets Ther.
9:5883–5895. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Berthier-Vergnes O, El Kharbili M, de la
Fouchardière A, Pointecouteau T, Verrando P, Wierinckx A, Lachuer
J, Le Naour F and Lamartine J: Gene expression profiles of human
melanoma cells with different invasive potential reveal TSPAN8 as a
novel mediator of invasion. Br J Cancer. 104:155–165. 2011.
View Article : Google Scholar :
|
|
13
|
Yue S, Mu W, Erb U and Zöller M: The
tetraspanins CD151 and Tspan8 are essential exosome components for
the crosstalk between cancer initiating cells and their
surrounding. Oncotarget. 6:2366–2384. 2015. View Article : Google Scholar :
|
|
14
|
Kanetaka K, Sakamoto M, Yamamoto Y,
Yamasaki S, Lanza F, Kanematsu T and Hirohashi S: Overexpression of
tetraspanin CO-029 in hepatocellular carcinoma. J Hepatol.
35:637–642. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gesierich S, Paret C, Hildebrand D, Weitz
J, Zgraggen K, Schmitz-Winnenthal F H, Horejsi V, Yoshie O, Herlyn
D, Ashman LK, et al: Colocalization of the tetraspanins, CO-029 and
CD151, with integrins in human pancreatic adenocarcinoma: Impact on
cell motility. Clin Cancer Res. 11:2840–2852. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hemler ME: Tetraspanin functions and
associated microdomains. Nat Rev Mol Cell Biol. 6:801–811. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yáñez-Mó M, Barreiro O, Gordon-Alonso M,
Sala-Valdés M and Sánchez-Madrid F: Tetraspanin-enriched
microdomains: A functional unit in cell plasma membranes. Trends
Cell Biol. 19:434–446. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zöller M: Tetraspanins: Push and pull in
suppressing and promoting metastasis. Nat Rev Cancer. 9:40–55.
2009. View
Article : Google Scholar
|
|
19
|
Nazarenko I, Rana S, Baumann A, McAlear J,
Hellwig A, Trendelenburg M, Lochnit G, Preissner KT and Zöller M:
Cell surface tetraspanin Tspan8 contributes to molecular pathways
of exosome-induced endothelial cell activation. Cancer Res.
70:1668–1678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei L, Li Y and Suo Z: TSPAN8 promotes
gastric cancer growth and metastasis via ERK MAPK pathway. Int J
Clin Exp Med. 8:8599–8607. 2015.PubMed/NCBI
|
|
21
|
Mao ZL, He SB, Sheng WH, Dong XQ and Yang
JC: Adenovirusmediated ING4 expression reduces multidrug resistance
of human gastric carcinoma cells in vitro and in vivo. Oncol Rep.
30:2187–2194. 2013.PubMed/NCBI
|
|
22
|
Soothill JS, Ward R and Girling AJ: The
IC50: An exactly defined measure of antibiotic sensitivity. J
Antimicrob Chemother. 29:137–139. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
24
|
Mi H, Muruganujan A and Thomas PD: PANTHER
in 2013: Modeling the evolution of gene function, and other gene
attributes, in the context of phylogenetic trees. Nucleic Acids
Res. 41:D377–D386. 2013. View Article : Google Scholar :
|
|
25
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:D447–D452. 2015. View Article : Google Scholar
|
|
26
|
Gan CS, Chong PK, Pham TK and Wright PC:
Technical, experimental, and biological variations in isobaric tags
for relative and absolute quantitation (iTRAQ). J Proteome Res.
6:821–827. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gong J, Shen S, Yang Y, Qin S, Huang L,
Zhang H, Chen L, Chen Y, Li S, She S, et al: Inhibition of FASN
suppresses migration, invasion and growth in hepatoma carcinoma
cells by deregulating the HIF-1α/IGFBP1 pathway. Int J Oncol.
50:883–892. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mitra A, Mishra L and Li S: EMT, CTCs and
CSCs in tumor relapse and drug-resistance. Oncotarget.
6:10697–10711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Clements WM, Wang J, Sarnaik A, Kim OJ,
MacDonald J, Fenoglio-Preiser C, Groden J and Lowy AM: β-Catenin
mutation is a frequent cause of Wnt pathway activation in gastric
cancer. Cancer Res. 62:3503–3506. 2002.PubMed/NCBI
|
|
30
|
Ma Y, Ren Y, Han EQ, Li H, Chen D, Jacobs
JJ, Gitelis S, O'Keefe RJ, Konttinen YT, Yin G, et al: Inhibition
of the Wnt-β-catenin and Notch signaling pathways sensitizes
osteosarcoma cells to chemotherapy. Biochem Biophys Res Commun.
431:274–279. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hartgrink HH, Jansen EPM, van Grieken NCT
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Loomis D, Huang W and Chen G: The
International Agency for Research on Cancer (IARC) evaluation of
the carcinogenicity of outdoor air pollution: Focus on China. Chin
J Cancer. 33:189–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wagner AD, Grothe W, Haerting J, Kleber G,
Grothey A and Fleig WE: Chemotherapy in advanced gastric cancer: A
systematic review and meta-analysis based on aggregate data. J Clin
Oncol. 24:2903–2909. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim DY, Kim JH, Lee SH, Kim TY, Heo DS,
Bang YJ and Kim NK: Phase II study of oxaliplatin, 5-fluorouracil
and leucovorin in previously platinum-treated patients with
advanced gastric cancer. Ann Oncol. 14:383–387. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shen DW, Pouliot LM, Hall MD and Gottesman
MM: Cisplatin resistance: A cellular self-defense mechanism
resulting from multiple epigenetic and genetic changes. Pharmacol
Rev. 64:706–721. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Krishna R and Mayer LD: Multidrug
resistance (MDR) in cancer. Mechanisms, reversal using modulators
of MDR and the role of MDR modulators in influencing the
pharmacokinetics of anticancer drugs Eur J Pharm Sci. 11:265–283.
2000.
|
|
37
|
Endo K, Maehara Y, Kusumoto T, Ichiyoshi
Y, Kuwano M and Sugimachi K: Expression of
multidrug-resistance-associated protein (MRP) and chemosensitivity
in human gastric cancer. Int J Cancer. 68:372–377. 1996.
View Article : Google Scholar
|
|
38
|
Yang YX, Xiao ZQ, Chen ZC, Zhang GY, Yi H
and Zhang PF: Proteome analysis of multidrug resistance in
vincristine-resistant human gastric cancer cell line SGC7901/ VCR.
Proteomics. 6:2009–2021. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
McCubrey JA, Lertpiriyapong K, Fitzgerald
TL, Martelli AM, Cocco L, Rakus D, Gizak A, Libra M, Cervello M,
Montalto G, et al: Roles of TP53 in determining therapeutic
sensitivity, growth, cellular senescence, invasion and metastasis.
Adv Biol Regul. 63:32–48. 2017. View Article : Google Scholar
|
|
40
|
Sheng Y, Ng CP, Lourie R, Shah ET, He Y,
Wong KY, Seim I, Oancea I, Morais C, Jeffery PL, et al: MUC13
overexpression in renal cell carcinoma plays a central role in
tumor progression and drug resistance. Int J Cancer. 140:2351–2363.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang J, Zhang Y, Liu T, Guo CH and Wan YF:
Reversal effect of inhibition of HSP90 activity on adriamycin
resistance of human hepatocellular carcinoma HepG2/ADR cells.
Tumor. 36:414–423. 2016.
|
|
42
|
Ren YP, Song C and Meng QK: Expression of
Tspan8 in colon cancer cell lines and effects of siRNA-mediated
Tspan8 gene silencing on the cell function of SW620. Zhongguo Yike
Daxue Xuebao. 44:34–37. 2015.In Chinese.
|
|
43
|
Castillo V, Valenzuela R, Huidobro C,
Contreras HR and Castellon EA: Functional characteristics of cancer
stem cells and their role in drug resistance of prostate cancer.
Int J Oncol. 45:985–994. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Niimi S, Nakagawa K, Yokota J, Tsunokawa
Y, Nishio K, Terashima Y, Shibuya M, Terada M and Saijo N:
Resistance to anticancer drugs in NIH3T3 cells transfected with
c-myc and/or c-H-ras genes. Br J Cancer. 63:237–241. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hayward P, Brennan K, Sanders P, Balayo T,
DasGupta R, Perrimon N and Martinez Arias A: Notch modulates Wnt
signalling by associating with Armadillo/β-catenin and regulating
its transcriptional activity. Development. 132:1819–1830. 2005.
View Article : Google Scholar : PubMed/NCBI
|
